Joan Schiller, MD, Oncology, Fairfax, VA

JoanHSchillerMD

Oncology Fairfax, VA

Hematologic Oncology, Thoracic Cancer

Oncologist at Inova Schar Cancer Institute

Dr. Schiller is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Schiller's full profile

Already have an account?

Education & Training

  • University of Wisconsin
    University of WisconsinFellowship, Medical Oncology, 1983 - 1987
  • McGaw Medical Center of Northwestern University
    McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1980 - 1983
  • University of Illinois College of Medicine
    University of Illinois College of MedicineClass of 1980

Certifications & Licensure

  • VA State Medical License
    VA State Medical License 2016 - 2022
  • TX State Medical License
    TX State Medical License 2007 - 2016
  • WI State Medical License
    WI State Medical License 1983 - 2011
  • IL State Medical License
    IL State Medical License 1981 - 2008
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2002-2014
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • American Society for Radiation Oncology(ASTRO): 20th Chicago Multidisciplinary Symposium inThoracic Oncology 
    American Society for Radiation Oncology, Chicago, Illinois - 9/6/2012

Press Mentions

  • Survey Shows Lung Cancer Stigma Has Decreased, More Awareness Still Needed
    Survey Shows Lung Cancer Stigma Has Decreased, More Awareness Still NeededSeptember 24th, 2019
  • Researchers Uncover Mutated Genes Involved in Lung Cancer; One Affects Nonsmokers
    Researchers Uncover Mutated Genes Involved in Lung Cancer; One Affects NonsmokersOctober 24th, 2017
  • South Carolina Alumnus Elected to Board of the National Association of EMS Physicians (ASPH -
    South Carolina Alumnus Elected to Board of the National Association of EMS Physicians (ASPH -February 18th, 2016
  • Join now to see all

Grant Support

  • Physician Scientist Oncology Training ProgramNational Cancer Institute2009–2011
  • Nm-404 As An Imaging Agent In Patients With Non-Small Cell Lung CancerNational Center For Research Resources2005–2006
  • Safety And Efficacy Of Abx-Egf, Paclitaxel And Carboplatin In NsclcNational Center For Research Resources2005
  • Pilot Study Of Liquid Crystal Nano-Structured Surfaces (Lc/Ns) AnalysesNational Center For Research Resources2005
  • Clinical Academic Oncologist Training ProgramNational Cancer Institute2005
  • Initial Human Safety Evaluation Of Nm404National Center For Research Resources2004–2005
  • Nano-Structure Surfaces And Liquid Crystal AnalysisNational Cancer Institute2004–2005
  • Safety And Efficacy Of ABT-510 PLUS Combination Chemotherapy In NsclcNational Center For Research Resources2004
  • Mid Career Investigator AwardNational Cancer Institute2000–2004
  • Academic Clinical Oncologist Training ProgramNational Cancer Institute2000–2004
  • CCNU In Nsclc Patients With Methylation Of The Mgmt GeneNational Cancer Institute2001–2003
  • Nm-404 A Novel Imaging Agent In Lung CancerNational Cancer Institute2002
  • Phase I Trial Of Docetaxel &KNational Center For Research Resources1999–2002
  • Phase I/II Trial Of Amifostine, High Dose Cisplatin, And Docetaxel In NsclcNational Center For Research Resources1998–2002
  • Phase III Randomized Study Of Intensive Cisplatin And Vinblastin +/- AmifostineNational Center For Research Resources1996–2002
  • Zeneca Zd0473 Combined With Topotecan In PTS W Refractory Solid MalignanciesNational Center For Research Resources2000
  • Msi-1256f (Squalamine Lactate) , Carboplatin, Paclitaxil In Nonsmal Cell Lung CanNational Center For Research Resources2000
  • Etoposide, Cisplatin, And Paclitaxel In Extensive SCLCNational Center For Research Resources2000
  • Adenovirus P53 In Bronchio-Alveolar Cell Lung CarcinomaNational Center For Research Resources2000
  • Squalamine PLUS Carboplatin And Paclitaxel In NSC Lung CNational Cancer Institute1999–2000
  • Phase I Evaluation Of CGP 69846a (Isis 5132)National Center For Research Resources1997–1999
  • Phase I Evaluation Of CGP 69846aNational Center For Research Resources1997–1999
  • Phase Ib/Ii Gmcsf And IL 2 In Renal Cell Carcinoma With Pulmonary MetastasesNational Center For Research Resources1996–1999
  • Clinical Testing Of Local BRM Delivery By Particle Mediated Gene TransferNational Cancer Institute1996–1999
  • Comparison Of Oral Ondansetron And IV Granisetron To Prevent Nausea &VomitingNational Center For Research Resources1997
  • Randomized Double Blind Comparison Of Oral Ondansetron And IV GranisetronNational Center For Research Resources1996
  • Phase II/III Randomized Study Of Cisplatin/Vinblastine PLUS Or Minus EthyolNational Center For Research Resources1995–1996
  • Cisplatin/Vinblastine And WR2721 PLUS Radiotherapy And WR2721 In NsclcNational Center For Research Resources1995–1996
  • Cisplatin In Hypertonic Saline, Vinblastine And Ethyol In Lung CancerNational Center For Research Resources1995–1996
  • Pilot Study Of Cisplatin/Vinblastine/Wr2721 Administered Without CI MannitolNational Center For Research Resources1995
  • Phase IB Granulocyte Macrophage Colony Stimulating Factor And IL2National Center For Research Resources1995
  • Laboratory-Clinical Correlative Studies In Lung CancerNational Cancer Institute1993–1995

Committees

  • Member, Update Committee of the ASCO NSCLC Expert Panel, American Society of Clinical Oncology 2015 - Present

Professional Memberships